[{"from": "human", "value": "What can you tell me about this molecule? [C][C][=C][C][=C][C][=C][Ring1][=Branch1][N][Branch1][=N][C][=C][C][=C][C][=C][Ring1][=Branch1][C][Ring1][#C][=O][C][=Branch1][C][=O][N]"}, {"from": "gpt", "value": "The molecule is an anti-epileptic medication used in the treatment of partial onset seizures that was first approved for use in the United States in 2000. It is a structural derivative of [carbamazepine] and exerts a majority of its activity via a pharmacologically active metabolite, MHD, which exists as a racemate in the blood - a pro-drug of the more active (S)-enantiomer is also marketed as a separate anti-epileptic under the name [eslicarbazepine]. Compared to other anti-epileptic drugs, which are generally metabolized via the cytochrome P450 system, oxcarbazepine has a reduced propensity for involvement in drug-drug interactions owing to its primarily reductive metabolism."}]